EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Dynamic Profiling of Circulating Tumor Cells and MYC/PTEN Alterations in Prostate Cancer Patients Undergoing Radical Prostatectomy in Amazon Population

Dynamisches Profiling zirkulierender Tumorzellen und MYC/PTEN-Veränderungen bei Prostatakrebs-Patienten unter radikaler Prostatektomie in einer Amazonen-Population

Juliana Ramos Chaves iD, Rommel Mario Rodriguez Burbano, Amanda de Nazaré Cohen-Paes, Diego Di Felipe Ávila Alcântara, Ana Paula Borges de Souza, Maria Janete Nahum Gomes, Sérgio Augusto Antunes Ramos, André Salim Khayat iD

Molecular Carcinogenesis · 2026-06 · 65 (6) · 665-676

DOI: 10.1002/mc.70104 ↗

Auf einen Blick

Bei 50 Patient:innen mit lokalisiertem Prostatakarzinom waren CTCs vor der Operation in allen Fällen nachweisbar und nach radikaler Prostatektomie deutlich seltener. PTEN-Verlust trat bei 12 % auf.

Fragestellung

Welche klinische Bedeutung haben zirkulierende Tumorzellen und MYC/PTEN-Veränderungen bei lokalisiertem Prostatakarzinom vor und nach radikaler Prostatektomie?

Methode

Prospektive Single-Center-Studie mit 50 Patient:innen aus dem brasilianischen Amazonasgebiet; Blutproben vor und nach radikaler Prostatektomie; CTC-Nachweis und molekulare Charakterisierung mit Cytelligen SET-iFISH und CellSearch.

Ergebnisse

CTCs wurden präoperativ bei allen Patient:innen gefunden, postoperativ kam es zu einer signifikanten Abnahme (p < 0,001); 88 % hatten nach der Operation keine nachweisbaren CTCs. PTEN-Verlust bei 12 %; MYC-Amplifikation bei 1 Patient:in.

Einschränkungen

Längere Nachbeobachtung nötig, um den prädiktiven Wert für Rezidiv und Langzeitergebnisse zu bestimmen.

Schlussfolgerung der Autor:innen

Die perioperative CTC-Detektion könnte klinisch relevante prognostische Informationen liefern. PTEN-Verlust scheint eine frühe molekulare Alteration mit ungünstigen pathologischen Merkmalen zu sein.

Kernaussagen

  • CTCs vor OP bei allen 50 Patient:innen nachweisbar
  • Nach OP bei 88 % keine nachweisbaren CTCs
  • PTEN-Verlust bei 12 %, MYC-Amplifikation selten

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Journal article in Molecular Carcinogenesis, published online on 2026-03-06. Written by Juliana Ramos Chaves and 7 co-authors. Institution: Laboratório de Medicina Molecular, Universidade Federal do Pará, Belém, Pará, Brazil. Major MEDLINE topics: Neoplastic Cells, Circulating, PTEN Phosphohydrolase, Prostatic Neoplasms, Biomarkers, Tumor. Cited 1 times so far (Crossref); 52 references. The full text is freely available (open access, CC BY 4.0). Funded by: Conselho Nacional de Desenvolvimento Científico e Tecnológico.

Auf einen BlickAstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Prostate cancer (PCa) is the second most frequently diagnosed malignancy among men and the sixth leading cause of cancer‐related mortality worldwide. Radical prostatectomy remains the standard treatment for localized disease; however, approximately one‐third of patients develop biochemical recurrence within 10 years. Although prostate‐specific antigen (PSA) is the primary biomarker used for diagnosis and monitoring, additional molecular markers such as PTEN loss and MYC amplification have been investigated to improve prognostic stratification. Liquid biopsy has emerged as a promising tool in oncology, yet the clinical significance of circulating tumor cells (CTCs) in early‐stage PCa remains uncertain. This prospective, single‐center study included 50 patients with localized prostate cancer from the Brazilian Amazon region who underwent radical prostatectomy in 2023. Peripheral blood samples were collected preoperatively and postoperatively for CTC enumeration and molecular characterization using Cytelligen SET‐iFISH and the CellSearch system. PTEN and MYC status were evaluated to further characterize the detected CTC population. CTCs were detected in all patients prior to surgery, with a significant reduction observed after radical prostatectomy ( p < 0.001); 88% of patients had no detectable CTCs postoperatively. PTEN loss was identified in 12% of patients, all of whom presented with ISUP grade ≥ 2 disease. MYC amplification was rare, observed in only one patient with Gleason score 7 and concomitant PTEN deletion. These findings suggest that perioperative CTC detection may provide clinically relevant prognostic information in localized PCa. PTEN loss appears to represent an early molecular alteration associated with adverse pathological features. Longer follow‐up is needed to determine the predictive value of these biomarkers for recurrence and long‐term outcomes.

Subjects

MeSH terms (MEDLINE)

Neoplastic Cells, CirculatingPTEN PhosphohydrolaseProstatic NeoplasmsBiomarkers, TumorProto-Oncogene Proteins c-mycHumansMaleProstatectomyBrazilMiddle AgedPrognosisAgedProspective StudiesLiquid Biopsy

Author keywords

PTEN/MYCbiomarkercirculating tumor cellsprostate cancersurgery

Substances

PTEN PhosphohydrolasePTEN protein, humanBiomarkers, TumorProto-Oncogene Proteins c-mycMYC protein, human

Authors and institutions

  • Laboratório de Medicina Molecular, Universidade Federal do Pará, Belém, Pará, Brazil.
  • Serviço de Urologia, Hospital Ophir Loyola, Belém, Pará, Brazil.
  • Núcleo de Pesquisas em Oncologia, Hospital Universitário João de Barros Barreto, R. dos Mundurucus, 4487 - Guamá, Belém, Pará, Brazil.

ORCID profiles: Juliana Ramos Chaves, André Salim Khayat

Funding

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Cite

APA

Chaves, J. R., Burbano, R. M. R., Cohen-Paes, A. N., Alcântara, D. D. F. Á., de Souza, A. P. B., Gomes, M. J. N., Ramos, S. A. A., & Khayat, A. S. (2026). Dynamic Profiling of Circulating Tumor Cells and MYC/PTEN Alterations in Prostate Cancer Patients Undergoing Radical Prostatectomy in Amazon Population. Molecular Carcinogenesis, 65(6), 665-676. https://doi.org/10.1002/mc.70104

Vancouver

Chaves JR, Burbano RMR, Cohen-Paes AN, Alcântara DDFÁ, de Souza APB, Gomes MJN, et al. Dynamic Profiling of Circulating Tumor Cells and MYC/PTEN Alterations in Prostate Cancer Patients Undergoing Radical Prostatectomy in Amazon Population. Molecular Carcinogenesis. 2026;65(6):665-676. doi:10.1002/mc.70104

BibTeX
@article{Chaves2026,
  author = {Chaves, Juliana Ramos and Burbano, Rommel Mario Rodriguez and Cohen-Paes, Amanda de Nazaré and Alcântara, Diego Di Felipe Ávila and de Souza, Ana Paula Borges and Gomes, Maria Janete Nahum and Ramos, Sérgio Augusto Antunes and Khayat, André Salim},
  title = {Dynamic Profiling of Circulating Tumor Cells and MYC/PTEN Alterations in Prostate Cancer Patients Undergoing Radical Prostatectomy in Amazon Population},
  journal = {Molecular Carcinogenesis},
  year = {2026},
  volume = {65},
  number = {6},
  pages = {665--676},
  doi = {10.1002/mc.70104}
}
Start for free →